Search
  • Site Search
  • News
  • Product

    • Zhejiang Medical Technology Development Co., Ltd.

    Zhejiang Medical Co., Ltd. put on "List of key to-be-listed enterprises in Hangzhou City"
    Zhejiang Medical Technology Development Co., Ltd. put on 'List of key to-be-listed enterprises in Hangzhou City' This afternoon, the new edition of 'List of key to-be-listed enterprises in Hangzhou City' was released. This is the fourth time that the Finance Office of Hangzhou has updated this list.  Compared with the list released in May 2019, the number of enterprises on this list has increased from 115 to 116, including Zhejiang Medical Technology Development Co., Ltd., a wholly-owned subsidiary of Hongkong Winhealth Pharma Group Co., Ltd.   In 2018, we c...
    Zhejiang Medical Co., Ltd. put on "List of key to-be-listed enterprises in Hangzhou City"
    Winhealth Pharma Group expands new cooperation in rare disease field
    'Hand in hand, combine research with applications', Winhealth Pharma Group expands new cooperation in rare disease field——Founding congress for Working Committee of Medication for Rare Diseases of Chinese Pharmacists Association and Sub-forum on Medication for Rare Diseases held  On November 1 to 3, 2019, the 11th Chinese Pharmacist Conference, with Winhealth Pharma Group as its strategic partner, was solemnly held in Tai'an, Shandong Province, the 'Hometown of Confucius and Mencius and Land of Etiquette'. Winhealth Pharma Group was brilliant at the conf...
    Winhealth Pharma Group expands new cooperation in rare disease field
    A strategic cooperation agreement was signed with Daiichi-Sankyo
    Hong Kong Winhealth Pharma Group (hereinafter referred to as Winhealth Pharma) declared to have come to a strategic cooperation agreement on Asmeton® product with Daiichi-Sankyo Pharmaceutical (Shanghai) Co., Ltd. (hereinafter referred to as Daiichi-Sankyo) on October 31, 2019.Daiichi-Sankyo will grant the right of promotion of Asmeton® in non-core regions in Chinese Mainland to Winhealth Pharma, and the latter will be responsible for commercial operation in non-core regions in Chinese Mainland, involving sales, channel management and product lifecycle management. Asmeton® ...
    A strategic cooperation agreement was signed with Daiichi-Sankyo
    Winhealth Pharma and Kyuan Trade develop new channel cooperation
    Hong Kong Winhealth Pharma Group and Kyuan Xinhai (Beijing) Medical Products Trade Co., Ltd. developed a long-term and comprehensive strategic cooperative partnership on the SPH system distribution of Compound Heparin Sodium and Allantoin Gel (manufactured by Merz Pharma GmbH & Co.KGaA) and Tauroursodeoxycholic Acid Capsules (manufactured by DOPPEL FARMACEUTICI S.R.L) in Hangzhou on October 29, 2019.General Manager Mr. Chu Chenxi and Vice-general Manager Mr. Zhang Dejun from Kyuan Xinhai (Beijing) Medical Products Trade Co., Ltd., President Mr. Wang Wei and Business Operations Director Mr....
    Winhealth Pharma and Kyuan Trade develop new channel cooperation
    Winhealth and JD.COM Pharmacy reached strategic cooperation agreement on Winhealth products
    Hongkong Winhealth Pharma Group Co., Ltd (hereinafter referred to as 'Winhealth Pharma Group') announced the formal establishment of a long-term strategic partnership on total products with JD.com self-operated pharmacy (hereinafter referred to as 'JD.COM Pharmacy').On September 30, 2019, the strategic cooperation signing ceremony between Winhealth Group and JD.COM Pharmacy was held as scheduled at the Beijing headquarters of JD.com. The main leaders attending the signing ceremony were: Hao Jinghui, Chief Commercial Officer; Chen Huiming, Commercial Operation Director; Tan Tian...
    Winhealth and JD.COM Pharmacy reached strategic cooperation agreement on Winhealth products
    2019 Mucosolvan conference for partners nationwide successfully held in Hangzhou
    On September 18, 2019, the 2019 Mucosolvan conference for partners nationwide kicked off at the Hangzhou headquarters. Featuring the theme of 'Win-win cooperation', the conference aimed to encourage partners to jointly develop with Winhealth, and make concerted efforts to promote Mucosolvan®. The representatives of 18 partners nationwide gathered together to witness this occasion.In addition, we were honored to invite Mr. Zeng Chenghui, vice president of Boehringer Ingelheim (China) Investment Co., Ltd and his management team as the guests of this conference. Mr. Wang Wei, board c...
    2019 Mucosolvan conference for partners nationwide successfully held in Hangzhou
    Winhealth won "BD Influence Award"!
    On September 11-12, 2019, the 14th Summit Forum for Medicine and Medical Technology Development in China, which was hosted by China Healthcare Business Development (CHBD), was successfully held in Yantai, Shandong Province.This summit forum was jointly hosted by Winhealth Group and LUYE Pharmaceutical, and more than 200 well-known domestic and foreign pharmaceutical enterprises, industry associations and investment institutions, such as Roche, Novartis, GSK, Xi'an-Janssen, WuXi PharmaTech, Hengrui Medicine, HEC, PwC, McKinsey & Company, and Sequoia Capital, were invited. A total of 7 c...
    Winhealth won "BD Influence Award"!
    3rd Floor, Winhealth Industrial Park, No. 272 Huancheng East Road, Xiacheng District, Hangzhou, Zhejiang, China
    BD@winhealth.Hk (overseas)
    0571-8718 6358
    Copyright ©2019 - 2024 Zhejiang Medical Technology Development Co., Ltd.
      网站地图
    浙ICP备12044547号
    Sitemap
    浙公网安备 33010302003458号